年龄、性别及2型糖尿病对于胃癌发生的风险: 一项单一机构的回顾性分析

doi:10.5246/jcps.2014.11.102

中国药学(英文版) ›› 2014, Vol. 23 ›› Issue (11): 799-803.DOI: 10.5246/jcps.2014.11.102

年龄、性别及2型糖尿病对于胃癌发生的风险: 一项单一机构的回顾性分析

王增¹, 蔡鑫君³, 刘孟娟¹, 卢红阳², 林能明^1,4*

1. 浙江省肿瘤医院药剂科, 浙江杭州 310022
2. 浙江省肿瘤医院胸部肿瘤诊治实验中心, 浙江杭州 310022
3. 杭州市红十字会医院药剂科, 浙江杭州 310005
4. 杭州市第一人民医院个体化医学研究所, 浙江杭州 310006

收稿日期:2014-04-07 修回日期:2014-05-27 出版日期:2014-11-24 发布日期:2014-06-10
通讯作者: Tel.: 86-571-88122438, Fax: 86-571-88122202
基金资助:
Zhejiang Provincial Science Program (Grant No. Y2110004) and Cultivation of High-level Innovation Health Talents (Grant No. 2010-190-4).

Age, gender and type 2 diabetes contribute to the risk of gastric cancer: a retrospective single institution analysis

Zeng Wang¹, Xinjun Cai³, Mengjuan Liu¹, Hongyang Lu², Nengming Lin^1,4*

1. Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou 310022, China
2. Zhejiang Key Lab of Diagnosis & Treatment Technology on Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China
3. Department of Pharmacy, Integrated Chinese and Western Medicine Hospital of Zhejiang Province, Hangzhou 310003, China
4. Institute for Individualized Medicine, Hangzhou First People’s Hospital, Hangzhou 310006, China

Received:2014-04-07 Revised:2014-05-27 Online:2014-11-24 Published:2014-06-10
Contact: Tel.: 86-571-88122438, Fax: 86-571-88122202
Supported by:
Zhejiang Provincial Science Program (Grant No. Y2110004) and Cultivation of High-level Innovation Health Talents (Grant No. 2010-190-4).

摘要/Abstract

摘要：

糖尿病与多种肿瘤的发生发展有关。然而, 与胃癌发生相关的潜在风险因素, 包括合并2型糖尿病(T2DM)是否与胃癌发生相关, 仍不清楚。本研究搜集了2010年1月~2012年12月我院收治的1320例胃癌患者(胃癌组)和1252个甲状腺结节的患者(对照组)的基本信息, 采用病例对照研究方法分析。应用Logistic回归分析评估合并T2DM情况、性别、年龄、身体质量指数(BMI)等对胃癌发生的影响。结果表明, 胃癌组中416例T2DM占31.5%, 对照组120例T2DM占9.6%, 两组间具有极其显著差异(P = 0.000)。与对照组相比, Logistic回归分析显示男性患者以及老年人群(年龄大于65岁)有较高发生胃癌的风险。此外, T2DM人群发生胃癌的风险也更高。年龄、T2DM、性别和体重指数的OR值分别为16.951, 15.130, 2.658和0.224。本研究表明年龄、性别和2型糖尿病是胃癌发生的危险因素之一, 即患有2型糖尿病且年龄在65岁以上的男性患者是胃癌的高发人群, 在这三个危险因素中, 患有2型糖尿病的风险值仅次于年龄, 也有可能是这些因素之间的共同作用导致胃癌的发生。

关键词: T2DM, 年龄, 性别, 胃癌, 危险因素

Abstract:

Diabetes is involved in the development of several cancers. However, whether type 2 diabetes mellitus (T2DM) as well as other potential risk factors are related to gastric cancer (GC) remains unclear. In this study, 1320 patients with gastric cancer (gastric cancer group) and 1252 thyroid nodule patients (control group), who were admitted in our hospital from Jan 2010 to Dec 2012, were analyzed in a case-control study. Logistic regression analysis was applied to evaluate the risk of diabetes condition, gender, age, body-mass index (BMI) level and other factors for GC. There were 416 patients with DM in the gastric cancer group (31.5%) and 120 patients with DM in the control group (9.6%). The differences between the two groups were significant (P = 0.000). Compared with the control group, the logistic regression analyses suggested that male patients had a higher risk of GC. Moreover, older individuals (especially over 65 years) were more susceptible to GC, and as for T2DM, it was found to be associated with GC, that is, the incidence in the gastric cancer group was significantly higher than in the control group. The OR values of age, T2DM, gender and BMI were 16.951, 15.130, 2.658 and 0.224, respectively. In conclusion, age, gender and T2DM are the risk factors of gastric cancer. Furthermore, male patient over 65 years with T2DM is susceptible to GC, and T2DM is the risk factor only second to age, and there might be synergistic effects among these factors.

Key words: T2DM, Age, Gender, Gastric cancer, Risk factor

中图分类号:

R969

Supporting:

王增, 蔡鑫君, 刘孟娟, 卢红阳, 林能明. 年龄、性别及2型糖尿病对于胃癌发生的风险: 一项单一机构的回顾性分析[J]. 中国药学(英文版), 2014, 23(11): 799-803.

Zeng Wang, Xinjun Cai, Mengjuan Liu, Hongyang Lu, Nengming Lin. Age, gender and type 2 diabetes contribute to the risk of gastric cancer: a retrospective single institution analysis[J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(11): 799-803.

参考文献

[1] Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Diabetes Care. 2004, 27, 1047-1053.

[2] World Healtt/Organization. Prevalence of diabetes-world map [R/OL]. [2009-10-30] http://who inl/diabetes/facts/en/index htm1.

[3] Heidemann, C.; Boeing, H.; Pischon, T.; Nothlings, U.; Joost, H.G.; Schulze, M.B. Eur. J. Epidemiol. 2009, 24, 281-288.

[4] Wells, B.J.; Kattan, M.W.; Cooper, G.S.; Jackson, L.; Koroukian, S. J. Am. Board. Fam. Med. 2014, 27, 42-55.

[5] Ben, Q.; Cai, Q.; Li, Z.; Yuan, Y.; Ning, X.; Deng, S, Wang, K. Eur. J. Cancer. 2011, 47, 248-254.

[6] Gold, H.T.; Makarem, N.; Nicholson, JM.; Parekh, N. Breast. Cancer. Res. Treat. 2014, Jan 18 [Epub ahead of print].

[7] Cavicchia, P.P.; Adams, S.A.; Steck, S.E.; Hussey, J.R.; Liu, J.; Daguisé, V.G.; Hebert, J.R. Cancer Causes Control. 2013, 24, 277-285.

[8] Parkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. CA. Cancer. J. Clin. 2005, 55, 74-108.

[9] Quiros, R.M.; Bui, C.L. Surg. Clin. North. Am. 2009, 89, 79viii-96viii.

[10] Jee, S.H.; Ohrr, H.; Sull, J.W.; Yun, J.E.; Ji, M.; Samet, J.M. JAMA. 2005, 293, 194-202.

[11] La Vecchia, C.; Negri, E.; Franceschi, S.; D’Avanzo, B.; Boyle, P. Br. J. Cancer. 1994, 70, 950-953.

[12] Inoue, M.; Iwasaki, M.; Otani, T.; Sasazuki, S.; Noda, M.; Tsugane, S. Arch. Intern. Med. 2006, 166, 1871-1877.

[13] Lin, S.W.; Freedman, N.D.; Hollenbeck, A.R.; Schatzkin, A.; Abnet, C.C. Cancer Epidemiol. Biomarkers. Prev. 2011, 20, 954-961.

[14] Tseng, C.H. Gut. 2011, 60, 774-779.

[15] Garcia, M.; Jemal, A.; Ward, E,M.; Center, M,M.; Hao, Y. Global Cancer Facts & Figures 2007. Atlanta, Georgia, American Cancer Society, 2007.

[16] National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007[article online], 2008. Atlanta, Georgia, Centers for Disease Control and Prevention. Available from http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf. Accessed 1 April 2010.

[17] Gong, Y.; Yang, Y.S.; Zhang, X.M.; Su, M.; Wang, J.; Han, J.D. World J. Gastroenterol. 2012, 18, 563-569.

[18] Ge, Z.; Ben, Q.; Qian, J.; Wang, Y.; Li, Y. Eur. J. Gastroenterol. Hepatol.2011, 23, 1127-1135.

[19] Chodick, G.; Heymann, A.D.; Rosenmann, L.; Green, M.S.; Flash, S.; Porath, A.; Kokia, E.; Shalev, V. Cancer Causes Control. 2010, 21, 879-887.

[20] Hemminki, K.; Li, X.; Sundquist, J.; Sundquist, K. Oncologist. 2010, 15, 548-555.

[21] Volkova, E.; Robinson, B.A.; Willis, J.; Currie, M.J.; Dachs, G.U. Oncol. Lett. 2014, 7, 311-320.

[22] Gu, M.J.; Bae, Y.K.; Choi, J.H. Hepatogastroenterology. 2013, 60, 1383-1386.

[23] Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective [article online], 2007. London, World Cancer Research Fund, American Institute for Cancer Research. Available from http://www.dietandcancerreport.org/. Accessed 1 April 2010.

年龄、性别及2型糖尿病对于胃癌发生的风险: 一项单一机构的回顾性分析

Age, gender and type 2 diabetes contribute to the risk of gastric cancer: a retrospective single institution analysis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价

[1]	周代英, 陈靓, 吕志刚. 基于网络药理学和分子对接探讨灯盏细辛治疗年龄相关性黄斑变性的机制[J]. 中国药学(英文版), 2023, 32(11): 923-934.
[2]	于丽娜, 高彩霞, 马俊, 郝雯瑾, 郑秋生. 胃癌抗氧化治疗的研究进展[J]. 中国药学(英文版), 2016, 25(6): 466-476.
[3]	李方园, 张贵育, 欧日兰, 王莹, 戚笑笑, 刘中秋, 卢琳琳. 中草药对幽门螺旋杆菌导致的胃癌的预防作用[J]. 中国药学(英文版), 2016, 25(4): 250-265.
[4]	吴妮, 徐嵬, 张友波, 杨秀伟. 马拉巴酮C的大鼠肝微粒体生物转化及其体外对人胃癌细胞株的细胞毒活性研究[J]. 中国药学(英文版), 2014, 23(4): 241-245.
[5]	孙莉, 贺瑞英, 李潇潇, 刘丽京, 邓艳萍. 吗啡处理大鼠的戒断症状以及血浆吗啡及其代谢物M3G含量的性别差异[J]. 中国药学(英文版), 2014, 23(2): 124-131.
[6]	孙莉, 李潇潇, 范华莹, 梁军成, 邓艳萍^*. 性别因素对替利定及其代谢物去甲替利定在中国健康志愿者中药代动力学的影响[J]. , 2012, 21(1): 93-100.
[7]	赵龙山, 高硕, 郭涛^*, 夏东亚. 性别因素对莫达非尼在中国健康志愿者体内的药动学的影响[J]. , 2010, 19(6): 477-481.
[8]	奚宝晨, 丁庆明, 史录文^* . 口服降糖药罗格列酮在临床应用中的危险因素分析 [J]. , 2008, 17(4): 332-336.
[9]	韩健, 叶敏, 乔雪, 吴婉莹, 曲桂芹, 果德安^* . 冬凌草甲素诱导胃癌BGC-823细胞凋亡及G₂/M细胞周期阻滞作用研究[J]. , 2007, 16(4): 307-314.
[10]	薛富善, 罗来葵, 孙伯华, 邹勤 . 潘库溴铵在婴儿、儿童和成年人的要到动力学[J]. , 1997, 6(4): 215-220.
[11]	肖军军, 崔景荣, 苏雅娴, 贺杰, 姚均恩 . 有机锡化合物抗肿瘤作用的研究[J]. , 1993, 2(1): 45-52.